Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Model Prescribing Information: Drugs Used in Leprosy
(1998; 28 pages) View the PDF document
The Revised Drug Strategy of the World Health Organization adopted in World Health Assembly Resolution WHA39.27 and revised in Resolution WHA49.14 in May 1996, calls for the preparation of model prescribing information to complement the WHO Model List of Essential Drugs. This will provide source material for adaptation by national authorities - particularly in developing countries - wishing to develop national drug formularies, drug compendia and similar material. This information is to be regarded as illustrative rather than normative. It is appreciated that it is not possible to develop an information sheet on a specific drug appropriate to circumstances prevailing in each of WHO’s Member States. Also, some countries have already formally adopted texts of their own that have a statutory connotation. This WHO Model Prescribing Information was written by the Division of Drug Management and Policies with the cooperation of the Action Programme for the Elimination of Leprosy, WHO, Geneva. It describes the WHO currently recommended drugs, doses and dosage regimens for leprosy.
Table of Contents
View the documentPreface
View the documentIntroduction
View the documentDiagnosis of leprosy
View the documentClassification of leprosy
View the documentTreatment of leprosy
View the documentTreatment of lepra reactions
View the documentTreatment of neuritis
View the documentTreatment of eye complications
View the documentManagement of nerve damage
View the documentTreatment of leprosy during pregnancy and lactation
View the documentTreatment of patient with concomitant active tuberculosis
View the documentTreatment of patients with concomitant HIV infection
Open this folder and view contentsTreatment of leprosy in special situations
Open this folder and view contentsDrug data sheets

WHO Model Prescribing Information: Drugs Used in Leprosy

Original: English
Distribution: General

World Health Organization

© World Health Organization (1998)

This document is not a formal publication of the World Health Organization (WHO) and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale or use in conjunction with commercial purposes.

The views expressed in documents by named authors are solely the responsibility of those authors.


to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018